Through cutting-edge research in the fields of ENERGY, HEALTH and MATTER, Helmholtz-Zentrum Dresden-Rossendorf (HZDR) solves some of the pressing societal and industrial challenges of our time. Join our 1.500 employees from more than 70 nations at one of our six research sites!
At the Institute of Radiooncology – OncoRay scientists (f/m/d) specializing in medicine, physics, biology and IT work together to crucially improve the treatment of cancer by administering radiation therapy that is biologically-personalized and technically-optimized.
At the Institute of Radiopharmaceutical Cancer Research scientists (f/m/d) from the fields of physics, chemistry, biology, pharmacy, immunology, medicine and IT develop innovative radiopharmaceuticals and novel tools for functional characterization, improved imaging and personalized treatment of tumors.
The Department of Translational Radiooncology and the department of Positron Emission Tomography are looking for a PhD student (f/m/d) shared between both institutes and working on the topic of Harmonized PET imaging for outcome prediction in cancer treatment.
Imaging of tumour glucose metabolism with FDG-based positron emission tomography (PET) is a cornerstone of diagnosis, therapy planning, and therapy response assessment in cancer treatment. In this project, we aim to predict the response of patients with head and neck cancer to radiochemotherapy using FDGPET imaging in two ways: (i) using quantitative PET parameters based on pharmacokinetic analysis and a novel tumour shape metric, (ii) using artificial-intelligence- based radiomics analysis of the images. Specifically, we aim to:
Kindly submit your completed application (including cover letter, CV, diplomas/
transcripts, etc.) only via our Online-application-system: https://www.hzdr.de/db/Cms?pNid=490&pLang=en&pOid=71746
ID: 182229